Deputy Director of Pharmacology and Toxicology Research Office, Institute of Radiology and Radiomedicine, Academy of Military Medical Sciences, Deputy Director of Key Laboratory of Drug Metabolism, and Director of Biotechnology Drug Metabolism Laboratory. He is also an expert in CDE new drug evaluation of the National New Drug Evaluation Center and an expert in military new drug evaluation. APS is a peer reviewer of China Journal of Pharmacology and Toxicology, China Journal of New Drugs and Academy of Military Medical Sciences. National natural science foundation, reviewer of national 863 project. Executive Committee of ABO Alliance Technical Committee.

Long-term engaged in pharmacological and pharmacokinetic research of biotechnological drugs. It has successively undertaken 2 national special projects of major new drug creation in the 11th Five-Year Plan, the special drug confidentiality project 1 required by the army in the 11th Five-Year Plan, the national "863" major project 1, the key project of the National Natural Science Foundation 1, 7 general project funds and 2 mandatory military projects. Undertake more than 70 horizontal cooperation projects in new drug research.

More than 60 papers have been published in core journals at home and abroad, and more than 20 papers have been included in SCI. The cumulative impact factor exceeds 30, and the cumulative citation times of major papers exceed 40. He has obtained 3 national invention patents and written 2 monographs on biotechnology drugs. Train 25 graduate students and assist in training doctoral students 10.